FDA rushed to approve new drugs in 2019, sometimes way ahead of schedule. Could that be dangerous? – Endpoints News

Share this Story

While the roster of 48 drugs (plus 4 notable biologics) the FDA approved in 2019 didn’t break any records with the sheer number it was remarkable in one aspect: The agency reached deep into a group of therapies they didn’t need to make a decision on until lat…

Author: Amber Tong